BCPC — BALCHEM CORP
—
Nasdaq ·
Materials ·
Chemicals ·
CIK 9326 ·
Last close
$169.63
Market Cap
$5.41B
52W High
$186.15
52W Low
$146.28
ADV30
299,800
Next earnings
2026-10-23
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 290,658,000 | 105,714,000 | 62,437,000 | 46,728,000 | 1,703,572,000 | 66,264,000 | 376,795,000 |
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 270,709,000 | 101,084,000 | 55,626,000 | 40,285,000 | 1,693,742,000 | 72,873,000 | 408,626,000 |
| Dec 2025 | 263,617,000 | 93,899,000 | 52,290,000 | 39,225,000 | 1,686,252,000 | 74,570,000 | 428,839,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$220,160,000
Investing CF
$-44,271,000
Financing CF
$-155,624,000
CapEx
$-44,182,000
Dividends Paid
$-30,793,000
Buybacks
$-118,001,000
EPS Diluted TTM
$5.09
As of
2026-10-25
Balance + Analyst (yfinance extras)
Retained Earnings
$1,161,681,000
Inventory
$146,743,000
Receivables
$154,232,000
ST Investments
—
EBIT TTM
$213,120,000
Pretax Income TTM
$203,612,000
Interest Exp TTM
$9,508,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,108,980,992
EBITDA
$278,078,016
Free Cash Flow
$139,495,120
Enterprise Value
$5,700,766,208
Total Cash
$66,264,000
Total Debt
$142,444,000
Shares Out
31,878,021
Trailing EPS
$5.08
Book Value
$40.76
ROE
13.0%
ROA
8.5%
Div Yield
0.54%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,037,161,000 | 209,326,000 | 154,845,000 | 1,686,252,000 | 428,839,000 | 1,257,413,000 | 216,556,000 |
| Dec 2024 | 953,684,000 | 182,909,000 | 128,475,000 | 1,575,371,000 | 425,458,000 | 1,149,913,000 | 181,999,000 |
| Dec 2023 | 922,439,000 | 159,193,000 | 108,543,000 | 1,597,211,000 | 543,227,000 | 1,053,984,000 | 183,761,000 |
| Dec 2022 | 942,358,000 | 145,186,000 | 105,367,000 | 1,624,512,000 | 686,228,000 | 938,284,000 | 138,536,000 |
TTM Snapshot
Revenues TTM
$1,085,881,000
NetIncome TTM
$164,414,000
OpCashFlow TTM
—
Assets (Latest)
$1,687,004,000
Forward EPS
$6.27
Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $185.00 · spot: $168.73 · call volume: 28 · put volume: 10Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CE | Celanese Corp | $5.34B | $48.66 | — |
| ICL | ICL Group Ltd. | $5.59B | $4.33 | — |
| MEOH | METHANEX CORP | $5.19B | $67.03 | — |
| HXL | HEXCEL CORP /DE/ | $5.79B | $76.42 | — |
| SXT | SENSIENT TECHNOLOGIES CORP | $4.97B | $116.76 | — |
News headlines (Yahoo Finance, 1h cache)
Balchem Corporation to Participate in Baird’s Global Industrial Conference on November 11, 2026
2026-10-28 11:00 · Yahoo
Balchem (BCPC) Stock Can Q3 Earnings Spark A Bigger Rerating?
2026-10-25 09:11 · Yahoo
Balchem Corporation Q3 2026 Earnings Call Summary
2026-10-24 12:30 · Yahoo
Balchem: 3 Key Takeaways for Long-Term Investors
2026-10-23 18:32 · Yahoo
Balchem (BCPC) Q3 2026 Earnings Call Transcript
2026-10-23 18:13 · Yahoo
Balchem Corporation Reports Third Quarter 2026 Financial Results
2026-10-23 11:00 · Yahoo
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026
2026-10-09 11:00 · Yahoo
Vitamin K2 Market Forecasts Growth from $179.0M (2026) to $339.9M by 2031, Profiling Gnosis by Lesaffre, Balchem, J-OIL MILLS & Novonesis
2026-10-01 08:46 · Yahoo
Balchem (BCPC) Stock Looks Below Fair Value At Today’s Price
2026-09-25 18:09 · Yahoo
Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
2026-09-09 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.